Skip to main content

Viatris Inc income statement

  • VTRS · Nasdaq
  • Pharmaceuticals
  • S&P 500
$20.82+0.73%Close 13 Nov 2026

Viatris Inc reported revenue of $14.3 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), down 3.0% from fiscal 2024. Net income was −$3.51 billion and diluted earnings per share −$3.00.

From Viatris Inc's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Viatris Inc income statement, annual
USDFY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$11.43B$11.50B$11.95B$17.89B$16.26B$15.43B$14.74B$14.30B$14.73B
Revenue growth—+0.6%+3.9%+49.7%−9.1%−5.1%−4.5%−3.0%—
Cost of revenue$7.43B$7.60B$8.15B$12.31B$9.77B$8.99B$9.12B$9.29B$9.53B
Gross profit$4.00B$3.90B$3.80B$5.58B$6.50B$6.44B$5.62B$5.01B$5.20B
Gross margin35.0%33.9%31.8%31.2%40.0%41.7%38.2%35.1%35.3%
Research and development$704.5M$639.9M$555.1M$751.1M—————
Selling, general and administrative$2.44B$2.56B$3.34B$4.53B$4.18B$4.07B$4.10B$3.79B$4.04B
Operating expenses$3.10B$3.18B$4.01B$5.61B$4.88B$5.67B$5.61B$7.68B$5.20B
Operating income$905.6M$715.5M−$210.8M−$34.00M$1.61B$766.2M$10.10M−$2.66B−$4.60M
Operating margin7.9%6.2%−1.8%−0.2%9.9%5.0%0.1%−18.6%0.0%
Interest expense$542.3M$517.3M$497.8M$636.2M$592.4M$573.1M$550.0M$471.3M$472.8M
Income before tax$298.4M$154.4M−$721.2M−$664.4M$2.81B$202.9M−$623.2M−$3.67B−$526.4M
Income tax expense−$54.10M$137.6M−$51.30M$604.7M$734.6M$148.2M$11.00M−$150.1M$81.40M
Effective tax rate−18.1%89.1%7.1%−91.0%26.1%73.0%−1.8%4.1%−15.5%
Net income$352.5M$16.80M−$669.9M−$1.27B$2.08B$54.70M−$634.2M−$3.51B—
Net margin3.1%0.1%−5.6%−7.1%12.8%0.4%−4.3%−24.6%—
EPS · diluted$0.68$0.03−$1.11−$1.05$1.71$0.05−$0.53−$3.00—
Diluted weighted average shares517M517M601M1.2B1.2B1.2B1.2B1.2B1.2B
Basic weighted average shares515M516M601M1.2B1.2B1.2B———
EBITDA$3.02B$2.73B$2.01B$4.47B$4.64B$3.51B$2.90B$135.2M$2.81B
EBITDA margin26.4%23.8%16.8%25.0%28.5%22.7%19.7%0.9%19.1%
Depreciation & amortization$2.11B$2.02B$2.22B$4.51B$3.03B$2.74B$2.89B$2.80B$2.81B
Stock-based compensation−$3.30M$56.80M$79.20M$111.2M$116.4M$180.7M$146.1M$177.7M$175.9M
Dividends per share———$0.33$0.48$0.48$0.48$0.48$0.48

Quarterly

Viatris Inc income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$3.84B$3.66B$3.80B$3.75B$3.53B$3.25B$3.58B$3.76B$3.70B$3.52B$3.76B$3.75B
Cost of revenue$2.24B$2.16B$2.35B$2.29B$2.31B$2.09B$2.25B$2.39B$2.56B$2.36B$2.30B$2.31B
Gross profit$1.60B$1.50B$1.45B$1.46B$1.22B$1.16B$1.33B$1.37B$1.15B$1.16B$1.46B$1.44B
Gross margin41.6%41.1%38.1%38.9%34.4%35.7%37.2%36.5%31.0%32.9%38.8%38.4%
Research and development—$199.7M$204.1M$198.4M—$222.0M$218.8M$250.4M—$248.6M$248.3M$231.7M
Selling, general and administrative$1.61B$1.02B$1.04B$1.00B$1.37B$948.1M$928.7M$886.6M$1.03B$928.8M$1.13B$950.8M
Operating expenses$2.05B$1.30B$1.69B$1.23B$1.39B$4.04B$1.10B$1.19B$1.34B$1.24B$1.45B$1.18B
Operating income−$454.5M$203.9M−$239.9M$225.9M−$179.8M−$2.88B$233.0M$178.8M−$192.7M−$79.70M$6.30M$261.5M
Operating margin−11.8%5.6%−6.3%6.0%−5.1%−88.6%6.5%4.8%−5.2%−2.3%0.2%7.0%
Interest expense$140.9M$138.4M$145.8M$145.6M$120.2M$115.5M$116.6M$119.6M$119.6M$120.1M$120.7M$112.4M
Income before tax−$855.0M$204.6M−$391.8M$90.50M−$526.5M−$3.10B−$217.1M−$7.90M−$343.0M−$247.3M−$64.00M$127.9M
Income tax expense−$89.40M$90.70M−$65.40M−$4.30M−$10.00M−$55.00M−$212.5M$120.3M−$2.90M−$423.7M$54.80M$453.2M
Effective tax rate10.5%44.3%16.7%−4.8%1.9%1.8%97.9%−1523%0.8%171%−85.6%354%
Net income—————————$176.4M−$118.8M−$325.3M
Net margin—————————5.0%−3.2%−8.7%
Net income to common shareholders—$113.9M−$326.4M$94.80M—−$3.04B−$4.60M−$128.2M—$176.4M−$118.8M−$325.3M
EPS · diluted—$0.09−$0.27$0.08—−$2.55$0.00−$0.11—$0.15−$0.10−$0.28
Diluted weighted average shares1.2B1.2B1.2B1.2B1.2B1.2B1.2B1.2B1.2B1.2B1.2B1.1B
Basic weighted average shares1.2B1.2B1.2B1.2B—1.2B1.2B1.2B—1.2B1.2B1.1B
EBITDA$189.9M$894.9M$546.4M$895.6M$566.4M−$2.22B$911.3M$867.3M$574.1M$596.4M$678.6M$958.7M
EBITDA margin4.9%24.4%14.4%23.9%16.1%−68.1%25.4%23.1%15.5%17.0%18.1%25.6%
Depreciation & amortization$644.4M$691.0M$786.3M$669.7M$746.2M$664.7M$678.3M$688.5M$766.8M$676.1M$672.3M$697.2M
Stock-based compensation$55.80M$46.70M$34.70M$32.40M$32.30M$55.20M$37.10M$36.00M$49.40M$48.20M$38.70M$39.60M
Dividends per share$0.12$0.12$0.12$0.12$0.12$0.12$0.12$0.12$0.12$0.12$0.12$0.12

The main figures as JSON and plain text. See data and methodology.

VTRS in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.